162 related articles for article (PubMed ID: 33324033)
1. Intravitreal Clindamycin as First-Line Therapy for Toxoplasmic Retinochoroiditis: A Case Series.
Verma L; Thulasidas M; Gupta A
Clin Ophthalmol; 2020; 14():4279-4285. PubMed ID: 33324033
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal clindamycin for toxoplasmic retinochoroiditis.
Sobrin L; Kump LI; Foster CS
Retina; 2007 Sep; 27(7):952-7. PubMed ID: 17891023
[TBL] [Abstract][Full Text] [Related]
3. Local treatment of toxoplasmic retinochoroiditis with intravitreal clindamycin and dexamethasone.
Zamora YF; Arantes T; Reis FA; Garcia CR; Saraceno JJ; Belfort R; Muccioli C
Arq Bras Oftalmol; 2015; 78(4):216-9. PubMed ID: 26375334
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial.
Baharivand N; Mahdavifard A; Fouladi RF
Int Ophthalmol; 2013 Feb; 33(1):39-46. PubMed ID: 23053769
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months.
Lasave AF; Díaz-Llopis M; Muccioli C; Belfort R; Arevalo JF
Ophthalmology; 2010 Sep; 117(9):1831-8. PubMed ID: 20471684
[TBL] [Abstract][Full Text] [Related]
6. Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis.
Jorge R; Coelho IN; Silva-Cunha A; Fernandes Cunha GM; Scott IU; Fialho SL; Furtado JM
Am J Ophthalmol Case Rep; 2021 Jun; 22():101093. PubMed ID: 33981913
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis.
Kishore K; Conway MD; Peyman GA
Ophthalmic Surg Lasers; 2001; 32(3):183-92. PubMed ID: 11371084
[TBL] [Abstract][Full Text] [Related]
8. Foveal reorganization after treatment of acute foveal toxoplasmic retinochoroiditis.
Abrishami M; Hosseini SM; Momtahen S; Zamani G
J Ophthalmic Inflamm Infect; 2021 Jun; 11(1):18. PubMed ID: 34151385
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal clindamycin in the treatment of unresponsive zone one toxoplasmic chorioretinitis: a case report.
Hosseini SM; Abrishami M; Mehdi Zadeh M
Iran Red Crescent Med J; 2014 Nov; 16(11):e15428. PubMed ID: 25763208
[TBL] [Abstract][Full Text] [Related]
10. [Intravitreal clindamycin injection in toxoplasma retinochoroiditis: About 9 cases in the ophthalmology department of the CHU de Bordeaux].
Handaye-Dessus A; Gattoussi S; Korobelnik JF; Delyfer MN; Rougier MB
J Fr Ophtalmol; 2021 Sep; 44(7):968-976. PubMed ID: 34247873
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case series.
Kianersi F; Naderi Beni A; Naderi Beni Z; Ghanbari H
Semin Ophthalmol; 2015 May; 30(3):181-7. PubMed ID: 24175641
[TBL] [Abstract][Full Text] [Related]
12. [Recurrent toxoplasmic retinochoroiditis after clindamycin treatment].
Benzina Z; Chaabouni S; Hentati N; Trigui A; Chaabouni F; Ben Salah S; Khlif H; Feki J
J Fr Ophtalmol; 2005 Nov; 28(9):958-64. PubMed ID: 16395222
[TBL] [Abstract][Full Text] [Related]
13. [Interest in treatment with subconjunctival clindamycin in toxoplasmic retinochoroiditis].
Ben Zina Z; Abid D; Kharrat W; Chaker N; Aloulou K; Chaâbouni M
Tunis Med; 2001 Mar; 79(3):157-60. PubMed ID: 11471444
[TBL] [Abstract][Full Text] [Related]
14. Atypical toxoplasmic retinochoroiditis.
Theodoropoulou S; Schmoll C; Templeton K; Dhillon B
BMJ Case Rep; 2012 May; 2012():. PubMed ID: 22669878
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal Clindamycin and Dexamethasone Combined with Systemic Oral Antitoxoplasma Therapy versus Intravitreal Therapy Alone in the Management of Toxoplasma Retinochoroiditis: A Retrospective Study.
Bor'i A; Mahrous A; Al-Aswad MA; Al-Nashar HY; Nada WM; Wagih M; Awad AMB; El-Haig WM
J Ophthalmol; 2018; 2018():4160837. PubMed ID: 29619254
[TBL] [Abstract][Full Text] [Related]
16. Fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone administration.
Rush R; Sheth S
Indian J Ophthalmol; 2012; 60(2):141-3. PubMed ID: 22446913
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal Clindamycin as an Adjuvant Therapy in Congenital Toxoplasma Retinochoroiditis in a Neonate - A Case Report.
Upadhyaya A; Jalali S; Tyagi M; Parameswarappa DC
Ocul Immunol Inflamm; 2023 Feb; ():1-4. PubMed ID: 36758215
[TBL] [Abstract][Full Text] [Related]
18. Atypical toxoplasmic retinochoroiditis in patients with malignant hematological diseases.
Figueroa-Vercellino JP; Miguel L; Moll-Udina A; Alba-Linero C; Llorenç V; Adán A
Arch Soc Esp Oftalmol (Engl Ed); 2021 Mar; 96(3):152-156. PubMed ID: 32651033
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis.
Souza CE; Nascimento H; Lima A; Muccioli C; Belfort R
Ocul Immunol Inflamm; 2018; 26(7):1041-1044. PubMed ID: 28448726
[TBL] [Abstract][Full Text] [Related]
20. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
